CN112891509A - Seven-star tea granules and preparation method thereof - Google Patents
Seven-star tea granules and preparation method thereof Download PDFInfo
- Publication number
- CN112891509A CN112891509A CN202110120156.3A CN202110120156A CN112891509A CN 112891509 A CN112891509 A CN 112891509A CN 202110120156 A CN202110120156 A CN 202110120156A CN 112891509 A CN112891509 A CN 112891509A
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- qixing
- extract
- granules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 77
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 127
- 235000013616 tea Nutrition 0.000 claims abstract description 90
- 239000000284 extract Substances 0.000 claims abstract description 64
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 39
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 37
- 235000020279 black tea Nutrition 0.000 claims abstract description 37
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 37
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 35
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 29
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 22
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 22
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 22
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 22
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 22
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 22
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 22
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 22
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 22
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 22
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 22
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 22
- 240000003915 Lophatherum gracile Species 0.000 claims abstract description 22
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 22
- 235000011477 liquorice Nutrition 0.000 claims abstract description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 21
- 239000008103 glucose Substances 0.000 claims abstract description 21
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000012874 Phaseolus calcaratus Nutrition 0.000 claims abstract description 20
- 240000001417 Vigna umbellata Species 0.000 claims abstract description 20
- 235000011453 Vigna umbellata Nutrition 0.000 claims abstract description 20
- 210000003038 endothelium Anatomy 0.000 claims abstract description 20
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 241000736199 Paeonia Species 0.000 claims description 40
- 241001092040 Crataegus Species 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 9
- 238000007873 sieving Methods 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 230000009849 deactivation Effects 0.000 claims description 3
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 2
- 230000029087 digestion Effects 0.000 abstract description 7
- 229930014626 natural product Natural products 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 14
- 235000019225 fermented tea Nutrition 0.000 description 12
- 230000000694 effects Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 230000008602 contraction Effects 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 210000002460 smooth muscle Anatomy 0.000 description 6
- 244000077995 Coix lacryma jobi Species 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 239000004365 Protease Substances 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 102000004400 Aminopeptidases Human genes 0.000 description 3
- 108090000915 Aminopeptidases Proteins 0.000 description 3
- 108010004032 Bromelains Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 108010059820 Polygalacturonase Proteins 0.000 description 3
- 235000019835 bromelain Nutrition 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 108010093305 exopolygalacturonase Proteins 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000931705 Cicada Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 241000157352 Uncaria Species 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 108010007119 flavourzyme Proteins 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000131458 Elsholtzia Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008773 effect on children Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006068 taste-masking agent Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicine preparations, and particularly relates to a Qixing tea granule and a preparation method thereof, wherein the Qixing tea granule comprises the following components in parts by weight: 1-5 parts of liquorice, 1-5 parts of lophatherum gracile, 4-10 parts of endothelium corneum gigeriae galli, 4-10 parts of hawthorn, 4-10 parts of malt, 4-10 parts of phaseolus calcaratus, 4-10 parts of semen coicis, 3-5 parts of peony protein peptide, 5-8 parts of black tea extract and 200 parts of glucose. The raw materials of the Qixing tea granules provided by the invention are all natural products, the medicine property is mild, the digestion function can be obviously improved, and the prepared Qixing tea granules have unique faint scent after being filled with water, are delicious to drink and are particularly suitable for children to drink.
Description
Technical Field
The invention belongs to the field of traditional Chinese medicine preparations, and particularly relates to a Qixing tea granule and a preparation method thereof.
Background
Some descriptions about Qixing tea are already provided in the Chinese medicinal prescriptions of the drug standards of Ministry of public health of the people's republic of China, the Qixing tea is prepared from Chinese medicinal materials including coix seeds, rice sprouts, hawthorn, lophatherum gracile, uncaria, cicada slough and liquorice, and preparations such as Qixing tea granules, Qixing tea syrup and the like are already provided at the present stage, so that the Qixing tea is a common medicament for pediatrics, has the effects of opening the stomach, eliminating stagnation, clearing heat and arresting convulsion, and is used for treating infantile indigestion, dyspepsia, poor appetite, dysphoria, easy fright, night sleep restlessness, unsmooth defecation and scan.
The technology is continuously developed, and higher requirements on the quality and the curative effect of the medicine are needed. Some formulations of Qixing tea have been favored by patients and relatives in recent years, but still have some problems in use.
Chinese patent CN103518902B discloses an adjuvant-free Qixing tea and a preparation method thereof, wherein wheat is used as a forming agent to avoid the ingestion of adjuvants, the adjuvants are usually substances such as starch, lactose and the like, the ingestion of the adjuvants for a long time can cause tooth decay or obesity of children, but the evaluation of a medicament, particularly children medicaments, the compliance of the medicament is also an important index, the adjuvants can be used as an effective taste masking agent to obviously increase the acceptance degree of children to the medicament, and the long-term taking of the adjuvants as a medicament is not likely to cause the obesity of children, the daily oral care is well made, the possibility of tooth decay caused by the administration of the medicament is not likely to be large, but the patent really indicates the improvement direction of the Qixing tea preparation, namely, the method is provided to reduce the side effect brought by the Qixing tea adjuvants and improve the compliance of the medicament.
Chinese patent application CN108904732A discloses a Qixing tea herbal tea granule for improving the digestive function of children and a preparation method thereof, wherein elsholtzia, mint and honey are added on the basis of the existing Qixing tea granule formula, and the curative effect on children suffering from excessive internal heat caused by eating milk powder or supplementary food is preliminarily verified in the form of cases, but the digestive function cannot be effectively improved.
In conclusion, although the Qixing tea granules are on the market for many years, different researchers still try to improve the formula of the Qixing tea granules, including the aspects of auxiliary materials, drug effects and the like, the novel formula and the preparation method of the Qixing tea granules are obtained through research, and compared with the prior art, the problems in the patents are really solved.
Disclosure of Invention
For the defects of the prior art, the invention aims to provide the seven-star tea granules and the preparation method thereof, the digestion function can be obviously improved, the prepared seven-star tea granules have unique faint scent after being filled with water, are delicious to drink, obviously enhance the compliance of medicines, can not induce the oral problems caused by auxiliary materials, and are particularly suitable for children to drink.
In order to achieve the purpose, the technical scheme of the invention is as follows:
the seven-star tea granule comprises the following components in parts by weight: 1-5 parts of liquorice, 1-5 parts of lophatherum gracile, 4-10 parts of endothelium corneum gigeriae galli, 4-10 parts of hawthorn, 4-10 parts of malt, 4-10 parts of phaseolus calcaratus, 4-10 parts of semen coicis, 3-5 parts of peony protein peptide, 5-8 parts of black tea extract and 200 parts of glucose.
Further, the composition comprises the following components in parts by weight: 3-5 parts of liquorice, 3-5 parts of lophatherum gracile, 6-10 parts of endothelium corneum gigeriae galli, 6-10 parts of hawthorn, 6-10 parts of malt, 6-10 parts of phaseolus calcaratus, 6-10 parts of semen coicis, 3-5 parts of peony protein peptide, 5-8 parts of black tea extract and 200 parts of glucose.
Further, the composition comprises the following components in parts by weight: 4 parts of liquorice, 4 parts of lophatherum gracile, 8 parts of endothelium corneum gigeriae galli, 8 parts of hawthorn, 8 parts of malt, 8 parts of phaseolus calcaratus, 8 parts of semen coicis, 5 parts of peony protein peptide, 7 parts of black tea extract and 200 parts of glucose.
Further, the preparation method of the peony protein peptide comprises the following steps:
1) pulverizing peony seed meal, and extracting with supercritical CO2Extracting, sieving, mixing with water, adjusting pH to 9, stirring, centrifuging, collecting supernatant, adjusting pH to 3, centrifuging, washing the obtained precipitate with water to neutrality, and freeze drying to obtain peony seed protein;
2) adding mixed enzyme I into the peony seed protein obtained in the step 1) for preliminary enzymolysis, adding mixed enzyme II for secondary enzymolysis after the preliminary enzymolysis, boiling secondary enzymolysis liquid for enzyme deactivation, centrifuging, filtering residues, and drying filtrate to obtain the peony protein peptide.
Further, the preparation method of the dark tea extract comprises the following steps: pulverizing black tea, decocting in water, filtering, concentrating the filtrate under reduced pressure to obtain black tea extract A, reflux-extracting the rest tea residue with ethanol twice, mixing the two ethanol extracts, concentrating under reduced pressure, drying to obtain black tea extract B, and mixing the black tea extract A and the black tea extract B to obtain the black tea extract.
The invention also provides a preparation method of the Qixing tea granules, which comprises the following specific steps:
s1, fully crushing liquorice, lophatherum gracile, endothelium corneum gigeriae galli, hawthorn, malt, phaseolus calcaratus and semen coicis according to the formula amount, sieving, adding water into the obtained traditional Chinese medicine powder, decocting, repeatedly decocting the residual medicine dregs for 1 time, and combining the water decoction of the two times;
s2, concentrating the water decoction obtained in the step S1 to obtain an extract, mixing the obtained extract with the black tea extract and the peony protein peptide, adding glucose, uniformly mixing, drying to obtain extract powder, and granulating the obtained extract powder to obtain the Qixing tea granules.
Further, the step S1 is to pass through a 60-100 mesh sieve.
Further, the water decoction conditions in step S1 are as follows: adding distilled water 3-7 times the weight of the Chinese medicinal powder, and decocting at 100-120 deg.C.
Further, the drying process parameters in the step S2 are as follows: the drying temperature is 120 ℃ and 180 ℃, and the drying time is 40-60 min.
Further, the process parameters of the granulation in the step S2 are as follows: the granulation pressure is 3MPa, the feeding speed is 350g/min, the mesh number of the upper screen is 15-18 meshes, and the mesh number of the lower screen is 30-40 meshes.
Compared with the prior art, the invention has the following advantages:
(1) the invention innovating the formula of the Qixing tea granules comprises liquorice, lophatherum gracile, endothelium corneum gigeriae galli, hawthorn, malt, phaseolus calcaratus, coix seeds, peony protein peptide and black tea extract, the prepared Qixing tea granules can effectively improve the digestive function of children patients, experiments prove that the added peony protein peptide and black tea extract and other components of the Qixing tea granules have obvious synergistic effect, and obviously enhance the contraction frequency of gastrointestinal smooth muscles of rabbits.
(2) The invention still retains the auxiliary materials, and the prepared Qixing tea granules have certain efficacy of inhibiting oral bacteria and can avoid oral cavity dental caries possibly caused by the application of the auxiliary materials.
(3) The preparation process is simple, the raw materials are all natural products, the medicine property is mild, the digestion function can be obviously improved, and the sensory evaluation of the water-filled Qixing tea granules fully proves that the prepared Qixing tea granules have unique faint scent after water filling, are delicious to drink, obviously improve the compliance of the medicine, and are particularly suitable for children to drink.
Detailed Description
The present invention will be further explained by way of specific embodiments in the form of examples. The scope of the above-described subject matter of the present invention is not limited to the following examples.
The medicinal materials, experimental medicines and reagents involved in the preparation method provided by the invention are all from conventional products sold in the market, but specific description is that the black tea used in the invention is Anhua Fuzhuan tea, the peony seed meal is purchased from Fumu fodder Co., Ltd, Tianjin, etc., the flavor protease and the bromelain are purchased from Anhui Zhonghong bioengineering Co., Ltd, and the pectinase and aminopeptidase are purchased from Jiangsu Ofu biotechnology Co., Ltd.
Example 1A method for preparing a Black tea extract
The preparation method of the dark tea extract comprises the following steps: crushing the dark tea, adding distilled water with the mass 5 times of that of the dark tea, decocting for 45min, filtering, concentrating the obtained filtrate under reduced pressure to obtain a dark tea extract A, performing reflux extraction on the residual tea residues through ethanol with the mass 8 times of that of the tea residues, repeating the reflux extraction twice, combining the two ethanol extracts, concentrating under reduced pressure, drying to obtain a dark tea extract B, and mixing the dark tea extract A and the dark tea extract B to obtain the dark tea extract.
Example 2 preparation method of peony protein peptide
1) Pulverizing peony seed meal, and extracting with supercritical CO2Extracting, sieving, mixing with water, adjusting pH to 9, stirring, centrifuging, collecting supernatant, adjusting pH to 3, centrifuging, washing the obtained precipitate with water to neutrality, and freeze drying to obtain peony seed protein;
2) adding a mixed enzyme I into the peony seed protein obtained in the step 1) for preliminary enzymolysis, wherein the mixed enzyme I is flavourzyme and pectinase, the mass ratio of the flavourzyme to the pectinase is 1:2, the enzymolysis pH is 7, the enzymolysis time is 3h, the enzymolysis temperature is 50 ℃, the amount of the added mixed enzyme I is 0.3% of the mass of the peony seed protein, after the preliminary enzymolysis, adding a mixed enzyme II for secondary enzymolysis, the mixed enzyme II is aminopeptidase and bromelain, the mass ratio of the aminopeptidase to the bromelain is 1:3, the enzymolysis pH is 8, the enzymolysis time is 2h, the enzymolysis temperature is 55 ℃, the amount of the added mixed enzyme II is 0.4% of the mass of the peony seed protein, boiling the secondary enzymolysis liquid for enzyme deactivation, centrifuging, filtering residues, and drying filtrate to obtain the peony protein peptide.
Example 3A Qixing tea granule
The Qixing tea granules comprise the following components in parts by weight: 1 part of liquorice, 1 part of lophatherum gracile, 4 parts of endothelium corneum gigeriae galli, 4 parts of hawthorn, 4 parts of malt, 4 parts of phaseolus calcaratus, 4 parts of semen coicis, 3 parts of peony protein peptide, 5 parts of black tea extract and 150 parts of glucose.
The preparation method of the Qixing tea granules comprises the following specific steps:
s1, fully crushing liquorice, lophatherum gracile, endothelium corneum gigeriae galli, hawthorn, malt, phaseolus calcaratus and semen coicis according to the formula, sieving by a 60-mesh sieve, adding distilled water with the mass 3 times of that of the traditional Chinese medicine powder into the obtained traditional Chinese medicine powder, decocting at the temperature of 100 ℃ for 40min, repeatedly decocting the residual medicine dregs for 1 time, and combining the water decoction of the two times;
s2, concentrating the water decoction obtained in the step S1 to obtain an extract, mixing the obtained extract with a formula amount of black tea extract and peony protein peptide, adding glucose, uniformly mixing, drying at 120 ℃, wherein the drying time is 40min, so as to obtain extract powder, granulating the obtained extract powder, and preparing the Qixing tea granules, wherein the granulating pressure is 3MPa, the feeding speed is 250g/min, the mesh number of an upper screen is 15 meshes, and the mesh number of a lower screen is 30 meshes.
Example 4A Qixing tea granule
The Qixing tea granules comprise the following components in parts by weight: 5 parts of liquorice, 5 parts of lophatherum gracile, 10 parts of endothelium corneum gigeriae galli, 10 parts of hawthorn, 10 parts of malt, 10 parts of phaseolus calcaratus, 10 parts of semen coicis, 5 parts of peony protein peptide, 8 parts of black tea extract and 200 parts of glucose.
The preparation method of the Qixing tea granules comprises the following specific steps:
s1, fully crushing liquorice, lophatherum gracile, endothelium corneum gigeriae galli, hawthorn, malt, phaseolus calcaratus and semen coicis according to the formula, sieving by a 60-mesh sieve, adding distilled water 7 times of the mass of the traditional Chinese medicine powder into the obtained traditional Chinese medicine powder, decocting at 120 ℃ for 40min, repeatedly decocting the residual medicine dregs for 1 time, and combining the water decoction of the two times;
s2, concentrating the water decoction obtained in the step S1 to obtain an extract, mixing the obtained extract with a formula amount of black tea extract and peony protein peptide, adding glucose, uniformly mixing, drying at 180 ℃ for 60min to obtain extract powder, granulating the obtained extract powder, and preparing the Qixing tea granules, wherein the granulating pressure is 3MPa, the feeding speed is 350g/min, the upper sieve mesh number is 18 meshes, and the lower sieve mesh number is 40 meshes.
Example 5A Qixing tea granule
The Qixing tea granules comprise the following components in parts by weight: 4 parts of liquorice, 4 parts of lophatherum gracile, 8 parts of endothelium corneum gigeriae galli, 8 parts of hawthorn, 8 parts of malt, 8 parts of phaseolus calcaratus, 8 parts of semen coicis, 5 parts of peony protein peptide, 7 parts of black tea extract and 200 parts of glucose.
The preparation method of the Qixing tea granules comprises the following specific steps:
s1, fully crushing liquorice, lophatherum gracile, endothelium corneum gigeriae galli, hawthorn, malt, phaseolus calcaratus and semen coicis according to the formula, sieving by a 80-mesh sieve, adding distilled water with the mass 5 times of that of the traditional Chinese medicine powder into the obtained traditional Chinese medicine powder, decocting at the temperature of 110 ℃ for 40min, repeatedly decocting the residual medicine dregs for 1 time, and combining the water decoction of the two times;
s2, concentrating the water decoction obtained in the step S1 to obtain an extract, mixing the obtained extract with a formula amount of black tea extract and peony protein peptide, adding glucose, uniformly mixing, drying at 160 ℃, drying for 50min to obtain extract powder, granulating the obtained extract powder, and preparing the Qixing tea granules, wherein the granulating pressure is 3MPa, the feeding speed is 300g/min, the upper sieve mesh number is 18 meshes, and the lower sieve mesh number is 30 meshes.
Example 6A Qixing tea granule
The Qixing tea granules comprise the following components in parts by weight: 3 parts of liquorice, 3 parts of lophatherum gracile, 6 parts of endothelium corneum gigeriae galli, 6 parts of hawthorn, 6 parts of malt, 6 parts of phaseolus calcaratus, 6 parts of semen coicis, 5 parts of peony protein peptide, 5 parts of black tea extract and 180 parts of glucose.
The preparation method of the seven-star tea granules is similar to that of example 5.
Comparative example 1A Qixing tea granule
The Qixing tea granules comprise the following components in parts by weight: 6 parts of liquorice, 6 parts of lophatherum gracile, 10 parts of endothelium corneum gigeriae galli, 10 parts of hawthorn, 10 parts of malt, 9 parts of phaseolus calcaratus, 9 parts of semen coicis and 200 parts of glucose.
The preparation method of the seven-star tea granules is similar to that of example 5.
The difference from example 5 is that the peony protein peptide and the dark tea extract were not added.
Comparative example 2 preparation method of Qixing tea granule
The Qixing tea granules comprise the following components in parts by weight: 5 parts of liquorice, 5 parts of lophatherum gracile, 9 parts of endothelium corneum gigeriae galli, 9 parts of hawthorn, 9 parts of malt, 8 parts of phaseolus calcaratus, 8 parts of coix seed, 7 parts of black tea extract and 200 parts of glucose.
The preparation method of the seven-star tea granules is similar to that of example 5.
The difference from example 5 is that no peony protein peptide was added.
Comparative example 3 preparation method of Qixing tea granule
The Qixing tea granules comprise the following components in parts by weight: 5 parts of liquorice, 5 parts of lophatherum gracile, 9 parts of endothelium corneum gigeriae galli, 9 parts of hawthorn, 9 parts of malt, 9 parts of phaseolus calcaratus, 9 parts of coix seed, 5 parts of peony protein peptide and 200 parts of glucose
The preparation method of the seven-star tea granules is similar to that of example 5.
The difference from example 5 is that no dark tea extract was added.
Comparative example 4A Qixing tea granule
The seven-star tea particles prepared by the method of Chinese patent CN103518902B comprise: 20.64% of coix seeds, 20.64% of rice sprouts, 20.00% of wheat, 15.49% of lophatherum gracile, 10.31% of hawthorn, 7.74% of uncaria, 2.59% of cicada slough and 2.59% of liquorice.
Experimental example 1 sensory evaluation of water-filled Qixing tea granules
Subject: seven-star tea granules prepared in example 5, comparative example 1 and comparative example 4.
The experimental method comprises the following steps: volunteers were recruited under conditions of random gender between adults (average age 20-40 years) and children (average age 6-15 years), wherein 18 adults and 36 children were divided into three groups (6 adults and 12 children per group), and the juxing tea granules prepared in example 5, comparative example 2 and comparative example 5 were tasted after filling with water, as shown in table 1, and the final results are shown in table 2:
table 1: sensory evaluation standard of water-filled Qixing tea granules
Table 2: sensory evaluation final result of water-filled Qixing tea granules
As can be seen from the data in table 2, the black tea extract and the peony protein peptide added in example 5 can enhance the sensory evaluation of the seven-star tea granules after being filled with water, and particularly, it is found in an investigation that volunteers recognize that the seven-star tea granules prepared in example 5 have strong fragrance after being filled with water, and after the bitterness of traditional Chinese medicines is shielded, the sweetness of glucose is reduced, the smell and the mouthfeel are prominent, and both adults and children are willing to accept the granules, comparative example 2 is a traditional method, and some volunteers cannot accept too sweet mouthfeel, but the whole is acceptable, while comparative example 5 is a formula without auxiliary materials in the prior art, the acceptance of adults is higher, but children cannot generally accept the granules, and the granules as a pediatric medicament need to meet the compliance of the medicament, so as to obtain the approval of the children. Particularly, the black tea extract is added into the Qixing tea granules in the example group, the existing research proves that the Qixing tea granules have the effect of inhibiting common oral bacteria, the black tea extract is added, the compliance of the medicine is improved, meanwhile, the effect of nursing the oral cavity is achieved, and the possible damage of glucose as an auxiliary material to teeth of children is avoided.
Experimental example 2 Effect of controlling digestive function
Subject: seven-star tea granules prepared in examples 3 to 6 and comparative examples 1 to 4.
The experimental method comprises the following steps: the regulation effect of different Qixing tea granules on the digestion function is verified by taking the contraction frequency of rabbit smooth muscle as a standard, and the specific operation is as follows:
the experimental rabbit is taken and fasted but not forbidden to be watered for 24 hours, killed by cervical dislocation, cut out smooth muscle specimen (average is 15mm multiplied by 5mm), placed in Leersi liquid (self-prepared) to be cleaned, fixed in a smooth muscle groove, accessed into a biological signal acquisition and processing system, added with different groups of Qixing tea particles to be watered to obtain solution for experiment (the drug content is 0.1g/L), and measured by interval measurement method for contraction frequency 5min before and 5min after dosing, and calculated for promotion rate [ the calculation formula of promotion rate is (post-dosing contraction frequency-pre-dosing contraction frequency)/pre-dosing contraction frequency multiplied by 100%).
The experimental results are as follows: as shown in table 3:
table 3: regulating effect of different Qixing tea granules on digestion function
As can be seen from table 3, the examples achieve better effect of promoting the gastrointestinal smooth muscle than the comparative examples, wherein example 5 is the most preferable example of the present invention, and the comparative examples show that the contraction frequency of the gastrointestinal smooth muscle is reduced to some extent by reducing the peony protein peptide or the dark tea extract, but the promotion rate of the combination of the two is obviously improved, and the synergistic effect of the two and other components in the particles of seven-star tea is verified, and the present invention has better effect of promoting digestion than the particles of seven-star tea provided by the prior art as seen from comparative example 4.
The experiments show that the raw materials used by the Qixing tea granules provided by the invention are all natural products, the medicine property is mild, the digestion function can be obviously improved, and the prepared Qixing tea granules have unique faint scent after being filled with water, are delicious to drink and are particularly suitable for children to drink.
Claims (10)
1. The Qixing tea granules are characterized by comprising the following components in parts by weight: 1-5 parts of liquorice, 1-5 parts of lophatherum gracile, 4-10 parts of endothelium corneum gigeriae galli, 4-10 parts of hawthorn, 4-10 parts of malt, 4-10 parts of phaseolus calcaratus, 4-10 parts of semen coicis, 3-5 parts of peony protein peptide, 5-8 parts of black tea extract and 200 parts of glucose.
2. The seven-star tea granule as claimed in claim 1, which comprises the following components in parts by mass: 3-5 parts of liquorice, 3-5 parts of lophatherum gracile, 6-10 parts of endothelium corneum gigeriae galli, 6-10 parts of hawthorn, 6-10 parts of malt, 6-10 parts of phaseolus calcaratus, 6-10 parts of semen coicis, 3-5 parts of peony protein peptide, 5-8 parts of black tea extract and 200 parts of glucose.
3. The seven-star tea granule as claimed in claim 2, which comprises the following components in parts by mass: 4 parts of liquorice, 4 parts of lophatherum gracile, 8 parts of endothelium corneum gigeriae galli, 8 parts of hawthorn, 8 parts of malt, 8 parts of phaseolus calcaratus, 8 parts of semen coicis, 5 parts of peony protein peptide, 7 parts of black tea extract and 200 parts of glucose.
4. The seven-star tea granule according to claim 1, wherein the preparation method of the peony protein peptide comprises:
1) pulverizing peony seed meal, and extracting with supercritical CO2Extracting, sieving, mixing with water, adjusting pH to 9, stirring, centrifuging, collecting supernatant, adjusting pH to 3, centrifuging, washing the obtained precipitate with water to neutrality, and freeze drying to obtain peony seed protein;
2) adding mixed enzyme I into the peony seed protein obtained in the step 1) for preliminary enzymolysis, adding mixed enzyme II for secondary enzymolysis after the preliminary enzymolysis, boiling secondary enzymolysis liquid for enzyme deactivation, centrifuging, filtering residues, and drying filtrate to obtain the peony protein peptide.
5. The seven-star tea granule according to claim 1, wherein the black tea extract is prepared by a method comprising: pulverizing black tea, decocting in water, filtering, concentrating the filtrate under reduced pressure to obtain black tea extract A, reflux-extracting the rest tea residue with ethanol twice, mixing the two ethanol extracts, concentrating under reduced pressure, drying to obtain black tea extract B, and mixing the black tea extract A and the black tea extract B to obtain the black tea extract.
6. The preparation method of the Qixing tea granules as claimed in any one of claims 1 to 5, which comprises the following steps:
s1, fully crushing liquorice, lophatherum gracile, endothelium corneum gigeriae galli, hawthorn, malt, phaseolus calcaratus and semen coicis according to the formula amount, sieving, adding water into the obtained traditional Chinese medicine powder, decocting, repeatedly decocting the residual medicine dregs for 1 time, and combining the water decoction of the two times;
s2, concentrating the water decoction obtained in the step S1 to obtain an extract, mixing the obtained extract with the black tea extract and the peony protein peptide, adding glucose, uniformly mixing, drying to obtain extract powder, and granulating the obtained extract powder to obtain the Qixing tea granules.
7. The method for preparing Qixing tea granules of claim 6 wherein step S1 is carried out through a 60-100 mesh sieve.
8. The preparation method of the Qixing tea granules of claim 6, wherein the conditions of the water decoction in step S1 are as follows: adding distilled water 3-7 times the weight of the Chinese medicinal powder, and decocting at 100-120 deg.C.
9. The method for preparing Qixing tea granules of claim 6 wherein the drying process parameters of step S2 are: the drying temperature is 120 ℃ and 180 ℃, and the drying time is 40-60 min.
10. The preparation method of the Qixing tea granules of claim 6, wherein the process parameters of the granulation in the step S2 are as follows: the granulation pressure is 3MPa, the feeding speed is 350g/min, the mesh number of the upper screen is 15-18 meshes, and the mesh number of the lower screen is 30-40 meshes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110120156.3A CN112891509A (en) | 2021-01-28 | 2021-01-28 | Seven-star tea granules and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110120156.3A CN112891509A (en) | 2021-01-28 | 2021-01-28 | Seven-star tea granules and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112891509A true CN112891509A (en) | 2021-06-04 |
Family
ID=76119740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110120156.3A Pending CN112891509A (en) | 2021-01-28 | 2021-01-28 | Seven-star tea granules and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112891509A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010130069A1 (en) * | 2009-05-15 | 2010-11-18 | 广州王老吉药业股份有限公司 | Use of pharmaceutical composition for preparing medicine for treating autoimmune disease |
| CN104623423A (en) * | 2015-01-23 | 2015-05-20 | 宁波立华制药有限公司 | Calming herbal tea and preparation method thereof |
| CN105475543A (en) * | 2015-11-16 | 2016-04-13 | 贺志弘 | Black tea composition for eliminating oral diseases like ozostomia and preparation method thereof |
| CN108543057A (en) * | 2018-05-28 | 2018-09-18 | 上海裕家农业科技发展有限公司 | A kind of blood-sugar reducing tea and preparation method thereof |
| CN110051821A (en) * | 2019-04-09 | 2019-07-26 | 世堃堂(广东)生物科技有限公司 | A kind of lower hyperlipidemia, hypertension, hyperglycemia adjusts taste activity compound peptide |
| CN110205352A (en) * | 2019-05-23 | 2019-09-06 | 世堃堂(广东)生物科技有限公司 | A kind of preparation method of tree peony protein peptides |
| CN110218755A (en) * | 2019-05-23 | 2019-09-10 | 世堃堂(广东)生物科技有限公司 | A kind of preparation method of hypoglycemic tree peony active peptide |
| CN110448656A (en) * | 2019-09-04 | 2019-11-15 | 河北地邦动物保健科技有限公司 | A kind of formula and preparation method thereof of seven-star tea granule |
-
2021
- 2021-01-28 CN CN202110120156.3A patent/CN112891509A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010130069A1 (en) * | 2009-05-15 | 2010-11-18 | 广州王老吉药业股份有限公司 | Use of pharmaceutical composition for preparing medicine for treating autoimmune disease |
| CN104623423A (en) * | 2015-01-23 | 2015-05-20 | 宁波立华制药有限公司 | Calming herbal tea and preparation method thereof |
| CN105475543A (en) * | 2015-11-16 | 2016-04-13 | 贺志弘 | Black tea composition for eliminating oral diseases like ozostomia and preparation method thereof |
| CN108543057A (en) * | 2018-05-28 | 2018-09-18 | 上海裕家农业科技发展有限公司 | A kind of blood-sugar reducing tea and preparation method thereof |
| CN110051821A (en) * | 2019-04-09 | 2019-07-26 | 世堃堂(广东)生物科技有限公司 | A kind of lower hyperlipidemia, hypertension, hyperglycemia adjusts taste activity compound peptide |
| CN110205352A (en) * | 2019-05-23 | 2019-09-06 | 世堃堂(广东)生物科技有限公司 | A kind of preparation method of tree peony protein peptides |
| CN110218755A (en) * | 2019-05-23 | 2019-09-10 | 世堃堂(广东)生物科技有限公司 | A kind of preparation method of hypoglycemic tree peony active peptide |
| CN110448656A (en) * | 2019-09-04 | 2019-11-15 | 河北地邦动物保健科技有限公司 | A kind of formula and preparation method thereof of seven-star tea granule |
Non-Patent Citations (2)
| Title |
|---|
| 宇凌等: "牡丹籽蛋白肽及牡丹叶粉对蛋鸡生产性能的影响", 《饲料博览》 * |
| 李远华主编: "《茶学综合实验》", 30 June 2018, 中国轻工业出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9345735B2 (en) | Fenugreek seed extract to lower blood cholesterol | |
| CN105995283A (en) | Composition capable of resisting fog and haze and nourishing lung, beverage capable of resisting fog and haze and nourishing lung and preparation method of beverage | |
| CN104666876A (en) | Traditional Chinese medicine for treating swollen sore throat | |
| CN103749735A (en) | Instant sugar-free high GABA (Gamma Amino Acid Butyric Acid) folium mori uncongealed beancurd and preparation method thereof | |
| CN103977206B (en) | Improve Chinese medicine preparation and the production method thereof of gastrointestinal disturbances systemic-function | |
| CN104757361B (en) | A kind of health drink for treating sphagitis | |
| CN110934963A (en) | Uric acid reducing composition, preparation method thereof, oral medicine and application | |
| CN105861252A (en) | Ganoderma lucidum health-care rice wine | |
| CN112891509A (en) | Seven-star tea granules and preparation method thereof | |
| CN1907374A (en) | Chinese medicinal composition for treating oral disease | |
| CN108813633A (en) | Wood frog ovum Gly-His-Lys | |
| CN114190556A (en) | Spleen-tonifying and stomach-nourishing food and preparation method thereof | |
| CN105535756A (en) | A traditional Chinese medicine composition helping digestion and sleeping for infants, a preparing method thereof and a preparation of the composition | |
| CN105477500A (en) | Traditional Chinese composition regulating intestine and stomach functions of infants and preparing method and preparation thereof | |
| CN111529642A (en) | Traditional Chinese medicine stick cream for children and preparation method thereof | |
| KR101858340B1 (en) | Composition for preventing or improving constipation comprising aloe fermented by nuruk as an active ingredient | |
| CN109172757A (en) | A kind of Chang Tong Bian Granules | |
| CN109480273A (en) | A kind of dendrobium nobile diet fiber health-care food and preparation method thereof | |
| CN107582829A (en) | A kind of functional food of cancer-resisting | |
| KR102275824B1 (en) | The anti-diabetes composition containing extract mixture and manufaturing method thereof | |
| CN102614426A (en) | Medicinal preparation and preparation method for helping digestion and removing stagnation | |
| CN107007739B (en) | Composition for improving or treating radiation oropharyngeal mucositis and preparation method and application thereof | |
| JP6427638B1 (en) | Composition for prevention, amelioration or treatment of sleep disorder, comprising a fermentation broth of Bacillus subtilis as an active ingredient | |
| CN1442068A (en) | Sea cucumber candy and its production method | |
| CN104940332A (en) | Fructo oligosaccharide composition for relaxing bowels and reducing flatulence and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210604 |